US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,479.55

+8.810.60%

Number of Gainers:8

Number of Losers:11

Number of Flat:- -

PE:- -

High:1,484.26

Open:1,470.85

Low:1,469.38

Close:1,470.74

Volume:121.73M

Turnover:4.60B

Market Cap:1.21T

Float Cap:1.19T

Loading ...

European Equities Traded in the US as ADRs Fall in Friday Trading

MT Newswires Live

Danantara Stays Quiet After Closed Microcredit Meeting at Parliament

BRIEF-FDA Hospira Discontinues Manufacture Of Gemcitabine Hydrochloride Injection 1 G/26.3 Ml, 2 G/52.6 Ml, 200 Mg/5.26 Ml - Website

Director James Buchan Reports Disposal of Common Shares of Alpha Pro Tech Ltd

AbbVie Hits Record High Since 2012 Spinoff from Abbott Laboratories

Bullish flow in Moderna with shares up 4.13%

Pfizer (PFE) and Greenstone Face US$71 Million Settlement in Antitrust Lawsuit

Simply Wall St.

Dr. Reddy's Laboratories Acquires STUGERON® Portfolio from Janssen Pharmaceutica for $50.5 Million to Expand CNS Portfolio

Co-Diagnostics performs in silico analysis of primers sets for chikungunya virus

Co-Diagnostics Inc. Achieves CE-Mark Regulatory Clearance for Logix Smart® ZDC Test, Enabling European Market Access for Zika, Dengue, and Chikungunya Diagnostics

Which Investments Do the Uber-Rich Favor? This Wall Street Pro Knows. -- Barrons.com

Protagonist Therapeutics Inc. Announces EMA Application Submission for Icotrokinra in Treating Moderate-to-Severe Plaque Psoriasis

Lakeland Industries price target lowered to $20 from $23 at DA Davidson

Poland - Factors to Watch September 11

Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects

BRIEF-Veeva Systems Says Gilead Sciences Commits To Veeva Vault CRM

European Equities Traded in the US as American Depositary Receipts Little Changed in Wednesday Trading

MT Newswires Live

Veeva Systems Expands Partnership With Gilead Sciences

MT Newswires Live

Gilead Sciences Selects Veeva Vault CRM for Enhanced Commercial Execution

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1479.5454,"timestamp":1758139199999,"preClose":1470.7393,"halted":0,"volume":121725920,"delay":0,"changeRate":0.005988,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":8.806152,"latestTime":"09-17 16:00:00 EDT","open":1470.8473,"high":1484.2612,"low":1469.3794,"amount":4598896470.848185,"amplitude":0.010119,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1758182400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.836858,"peRate":20.735352,"turnoverRate":0.007925,"increases":8,"decrements":11,"flats":0,"marketCap":1213866124832,"floatMarketCap":1194662475750.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1484.2612,"amplitude":0.010119,"preClose":1470.7393,"low":1469.3794,"pbRate":"3.836858","latestPrice":1479.5454,"volume":121725920,"delay":0,"open":1470.8473,"prevYearClose":1274.8187,"prevWeekClose":1488.5051,"prevMonthClose":1489.44,"prevQuarterClose":1377.5769,"fiveDayClose":1484.1697,"twentyDayClose":1501.6229,"sixtyDayClose":1360.6882,"secType":"PLATE","market":"US","turnoverRate":0.007925,"peRate":20.735352,"marketCap":1213866124832,"floatMarketCap":1194662475750.5,"timestamp":1758139199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566970138","title":"European Equities Traded in the US as ADRs Fall in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2566970138","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566970138?lang=en_us&edition=fundamental","pubTime":"2025-09-12 22:59","pubTimestamp":1757689142,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell late Friday morning with the S&P Europe Select ADR Index declining 0.5% to 1,533.9.From continental Europe, the decliners were led by biotech firm BioNTech  and biopharmaceutical company DBV Technologies , which fell 3.7% and 2.2% respectively. They were followed by telecommunications company Nokia  and Royal Philips , which were down 2.1% and 1.5% respectively.The gainers from continental Europe were led by biopharmaceutical company Cellectis  and furniture maker Natuzzi , which rose 3.9% and 3.6% respectively. They were followed by biopharmaceutical company Genfit  and pharmaceutical company Novo Nordisk , which were up 1.4% and 1% respectively.From the UK and Ireland, the decliners were led by biopharmaceutical company Akari Therapeutics  and software firm Endava , which dropped 2.4% and 1.8% respectively. They were followed by medical device maker Smith & Nephew  and cruise line operator Carnival , which lost 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","DAVA.AU","BK4082","NTZ","BK4139","CLLS","BK4551","BK4007","DAVA","BDRX","BK7104","BK4547","BK4548","BK4142","IE00BKVL7J92.USD","BK4134","ADAP","LU0154236417.USD","SNN","BK4585","LU0084288595.USD","NOK","LU0648005311.SGD","PHG","BK4568","BK4588","BK4020","LU1093756325.SGD","CUK","AKTX","IE00BMPRXR70.SGD","BK4095","NCNA","DBVT","GNFT","BK4599","BNTX","BK4535","LU1093756168.USD","AUTL","IE00BZ1G4Q59.USD","BK4532","IE00BMPRXN33.USD"],"gpt_icon":1},{"id":"2566945353","title":"Danantara Stays Quiet After Closed Microcredit Meeting at Parliament","url":"https://stock-news.laohu8.com/highlight/detail?id=2566945353","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566945353?lang=en_us&edition=fundamental","pubTime":"2025-09-12 07:23","pubTimestamp":1757632991,"startTime":"0","endTime":"0","summary":"TEMPO.CO,Jakarta - The Chief Operating Officer of the National Energy Investment Board , Dony Oskaria, remained silent after a closed-door meeting with the State Financial Accountability Body of the House of Representatives  on Thursday, September 11, 2025.The meeting, held at the Parliamentary Complex in Jakarta, centered on the governance of microcredit  and the preparation of financial reports.The meeting, which began at 10 a.m., concluded at 1 p.m. Following the session, Dony declined requests for interviews, instead directing journalists to the meeting's chair. As he departed, he stated, \"Ask Pak Andreas Eddy Susetyo .\"","market":"fut","thumbnail":"https://statik.tempo.co/data/2025/09/11/id_1427521/1427521_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/09/11/id_1427521/1427521_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2048121/danantara-stays-quiet-after-closed-microcredit-meeting-at-parliament","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2048121/danantara-stays-quiet-after-closed-microcredit-meeting-at-parliament","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4548","BK4568","BK7114","BK4585","BK4588","BNTX","BK4551","BRI.AU","BK4535","BK4139"],"gpt_icon":0},{"id":"2566931914","title":"BRIEF-FDA Hospira Discontinues Manufacture Of Gemcitabine Hydrochloride Injection 1 G/26.3 Ml, 2 G/52.6 Ml, 200 Mg/5.26 Ml - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2566931914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566931914?lang=en_us&edition=fundamental","pubTime":"2025-09-12 05:21","pubTimestamp":1757625714,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Hospira Discontinues Manufacture Of Gemcitabine Hydrochloride Injection 1 G/26.3 Ml, 2 G/52.6 Ml, 200 Mg/5.26 Ml - WebsiteSept 11  - Pfizer Inc PFE.N:FDA: HOSPIRA DISCONTINUES MANUFACTURE OF GEMCITABINE HYDROCHLORIDE INJECTION 1 G/26.3 ML, 2 G/52.6 ML, 200 MG/5.26 ML - WEBSITESource text: [ID:]Further company coverage: PFE.N ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nFWN3UY111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU0456855351.SGD","LU0225284248.USD","BK4533","LU0985481810.HKD","SG9999013999.USD","LU0306807586.USD","BK4599","SG9999001176.SGD","LU1894683264.USD","LU1066051498.USD","BK4588","PFE","IE00BBT3K403.USD","LU0225771236.USD","BK4592","BK4585","LU0868494617.USD","LU0321505439.SGD","BK4007","BK4534","BK4550","LU1023059063.AUD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999002232.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1066053197.SGD","BK4568","LU0321505868.SGD","LU0306806265.USD","BK4581","LU0058720904.USD","LU1894683348.USD","IE00B19Z3B42.SGD","SG9999001176.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1883839398.USD","SG9999002224.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2566171919","title":"Director James Buchan Reports Disposal of Common Shares of Alpha Pro Tech Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2566171919","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566171919?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:19","pubTimestamp":1757621995,"startTime":"0","endTime":"0","summary":"James Buchan, a Director at Alpha Pro Tech Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Pro Tech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL9xk19d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","APT","BK4568"],"gpt_icon":0},{"id":"1198298732","title":"AbbVie Hits Record High Since 2012 Spinoff from Abbott Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=1198298732","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198298732?lang=en_us&edition=fundamental","pubTime":"2025-09-12 03:30","pubTimestamp":1757619033,"startTime":"0","endTime":"0","summary":"During Thursday's late trading session in the U.S. stock market, AbbVie (ABBV) shares surged 4.21%, reaching a new peak since the pharmaceutical company spun off from Abbott Laboratories (ABT) and began trading independently in 2012.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU2468319806.SGD","LU1721429402.USD","IE0009355771.USD","LU2237957811.SGD","LU1057294990.SGD","LU1061106388.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","SGXZ23171101.USD","LU2089984988.USD","LU1721429741.USD","LU2133065610.SGD","LU0868494617.USD","LU0882574055.USD","LU2324357040.USD","LU0170899867.USD","LU1989763690.USD","BK4588","BK4592","LU2211815571.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4581","BK4533","SG9999004303.SGD","BK4585","SG9999002232.USD","LU1989763427.SGD","IE00B2B36J28.USD","LU0234572021.USD","BK4504","LU1691799644.USD","SG9999002224.SGD","LU0114720955.EUR","LU0266013472.USD","BK4082","IE0002141913.USD","LU1023059063.AUD","LU2237957902.USD","LU1914381329.SGD","ABT","IE00BJT1NW94.SGD","BK4566"],"gpt_icon":0},{"id":"2566391304","title":"Bullish flow in Moderna with shares up 4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566391304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566391304?lang=en_us&edition=fundamental","pubTime":"2025-09-12 01:45","pubTimestamp":1757612713,"startTime":"0","endTime":"0","summary":"Bullish flow in Moderna (MRNA), with shares up $1.00, or 4.13%, near $25.32. Options volume relatively light with 30k contracts traded and calls le...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bullish-flow-in-moderna-with-shares-up-4-13-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bullish-flow-in-moderna-with-shares-up-4-13-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4548","BK4533","BK4112","BK4501","BK4532","BK4588","BK4534","BK4585","BK4551","BK4568","MRNA"],"gpt_icon":0},{"id":"2566902915","title":"Pfizer (PFE) and Greenstone Face US$71 Million Settlement in Antitrust Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2566902915","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566902915?lang=en_us&edition=fundamental","pubTime":"2025-09-12 01:32","pubTimestamp":1757611952,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) recently announced proposed class action settlements totaling approximately $71 million related to allegations of antitrust violations, while also facing a patent infringement lawsuit over its COVID-19 antiviral, Paxlovid. Despite these legal challenges, Pfizer's share price remained largely flat over the past month, reflecting broader market stability amidst record highs in major U.S. stock indexes. Meanwhile, positive developments in their COVID-19 vaccine trials and FDA...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-and-greenstone-face-us71-million-settlement-in-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-and-greenstone-face-us71-million-settlement-in-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0985481810.HKD","LU0456855351.SGD","LU0058720904.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU0122379950.USD","BK4599","PFE.AU","LU0234572021.USD","SG9999013999.USD","SG9999011175.SGD","SG9999002224.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU0306807586.USD","IE00BLSP4452.SGD","BK4533","BK4007","IE0002270589.USD","LU0225771236.USD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0321505868.SGD","BK4588","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","LU0321505439.SGD","BK7095","SG9999001176.SGD","LU1057294990.SGD","LU0170899867.USD","LU1066051498.USD","LU1894683264.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4568","PFE","SG9999003800.SGD","IE00BLSP4239.USD","BK4534","BK4585","BK4581","LU0225284248.USD","BK4550"],"gpt_icon":0},{"id":"2566992515","title":"Dr. Reddy's Laboratories Acquires STUGERON® Portfolio from Janssen Pharmaceutica for $50.5 Million to Expand CNS Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2566992515","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566992515?lang=en_us&edition=fundamental","pubTime":"2025-09-11 22:54","pubTimestamp":1757602460,"startTime":"0","endTime":"0","summary":"Dr. Reddy's Laboratories Limited has announced a definitive agreement to acquire the STUGERON brand from Janssen Pharmaceutica NV, an affiliate of Johnson & Johnson. The acquisition includes the leading local brands Stugeron FORTE and Stugeron PLUS, along with related assets, across 18 markets in the Asia-Pacific and Europe, Middle East, and Africa regions, with India and Vietnam as key markets. The transaction, valued at USD 50.5 million, aims to bolster Dr. Reddy's Central Nervous System Portfolio, particularly in the anti-vertigo segment. The operations of the acquired portfolio will be gradually transitioned to ensure a smooth integration into Dr. Reddy's existing business.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL7QpVz6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU0070217475.USD","LU0289739699.SGD","LU1066051811.HKD","LU1674673428.USD","LU0345769128.USD","LU1894683348.USD","BK4550","LU0203345920.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1023059063.AUD","LU1196500208.SGD","LU1732800096.USD","LU2471134879.HKD","LU2592432038.USD","IE0009355771.USD","LU0432979614.USD","BK4559","IE000M9KFDE8.USD","BK4568","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","IE00B3T34201.USD","JNJ","LU0985320562.USD","LU1718418525.SGD","BK4533","LU2468319806.SGD","LU2471134523.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU2129689605.HKD","LU1221951129.SGD","BK4588","LU1066051498.USD","LU1430594728.SGD","IE00BLSP4452.SGD","BK4585","IE00BGHQF631.EUR","LU1267930813.SGD","LU0345770308.USD","LU2430703178.SGD","LU2129689431.USD","IE00BVYPNW00.USD","LU1032955483.USD","LU1066053197.SGD","LU1935042991.SGD","LU1506573853.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2566562991","title":"Co-Diagnostics performs in silico analysis of primers sets for chikungunya virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2566562991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566562991?lang=en_us&edition=fundamental","pubTime":"2025-09-11 21:50","pubTimestamp":1757598645,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) has performed an in silico analysis of the primers sets used in its Co-Primers based PCR tests for the detection of chikungun...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-performs-in-silico-analysis-of-primers-sets-for-chikungunya-virus-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-performs-in-silico-analysis-of-primers-sets-for-chikungunya-virus-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"gpt_icon":0},{"id":"2566999638","title":"Co-Diagnostics Inc. Achieves CE-Mark Regulatory Clearance for Logix Smart® ZDC Test, Enabling European Market Access for Zika, Dengue, and Chikungunya Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2566999638","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566999638?lang=en_us&edition=fundamental","pubTime":"2025-09-11 21:30","pubTimestamp":1757597431,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. Achieves CE-Mark Regulatory Clearance for Logix Smart ZDC Test, Enabling European Market Access for Zika, Dengue, and Chikungunya Diagnostics. Co-Diagnostics Inc., a molecular diagnostics company, announced a significant milestone in regulatory approval for its Logix Smart ZDC Test. The test, which received CE-marking regulatory clearance in 2019, is designed to detect and differentiate Zika, dengue, and chikungunya viruses using the company's patented Co-Primers technology. This approval allows the test to be marketed as an in vitro diagnostic in regions accepting CE-marking, pending local registration. Additionally, Co-Diagnostics' Indian joint venture, CoSara Diagnostics Pvt Ltd, received clearance in October 2021 to manufacture and sell the SaraGene Dengue and Chikungunya Multiplex RT-PCR test in India. These advancements underscore the company's progress in expanding its diagnostic solutions globally.Disclaimer: This news brief was created by Public Technologie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL6kkhJ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2566998026","title":"Which Investments Do the Uber-Rich Favor? This Wall Street Pro Knows. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2566998026","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566998026?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:06","pubTimestamp":1757592360,"startTime":"0","endTime":"0","summary":"Sara Naison-Tarajano wears numerous hats at Goldman Sachs, where she works with many of the richest families in the world. A Goldman partner, she is global head of private wealth management capital markets, and Goldman Sachs Apex, which brings investment deals to client families. She is also co-head of One Goldman Sachs, which integrates investment banking, asset management, and wealth management services. And, she runs the Goldman Sachs Partner Family Office for top executives of the firm.Naison-Tarajano, who says that all of her roles \"sort of connect,\" has been at Goldman for 26 years, since joining the firm's analyst program right out of college.Goldman has surveyed professionals running the family offices of the uber-rich, two-thirds of which have assets of $1 billion or more, biennially since 2021, to glean insights into what drives their investment priorities and outlook. She recently spoke with Barron's about the results of the latest survey, released on Sept. 10, which indicat","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","BK4588","UBER","LU0106261372.USD","LU2750360997.AUD","LU0006306889.USD","IE0002270589.USD","SG9999014898.SGD","BK4533","SG9999014914.USD","LU1316542783.SGD","LU1894683264.USD","BK4536","LU2237443978.SGD","SG9999018857.SGD","BK4503","LU1988902786.USD","IE0034235188.USD","IE0004086264.USD","LU1861214812.USD","SGXZ81514606.USD","BK4585","BK4568","LU0061475181.USD","LU0353189680.USD","SG9999015945.SGD","BK4551","LU1804176565.USD","LU0096364046.USD","LU2237443895.HKD","SG9999017495.SGD","LU1983260115.SGD","IE00B19Z3581.USD","SG9999015978.USD","BK4535","LU0251131958.USD","LU0127658192.USD","BK4505","MRNA","SGXZ51526630.SGD","LU2471134523.USD","LU2471134879.HKD","LU1668664300.SGD","GB00BDT5M118.USD","LU2237957811.SGD","IE0004091025.USD","LU0107464264.USD","BK4548","LU0742534661.SGD"],"gpt_icon":1},{"id":"2566980609","title":"Protagonist Therapeutics Inc. Announces EMA Application Submission for Icotrokinra in Treating Moderate-to-Severe Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2566980609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566980609?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:05","pubTimestamp":1757592331,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics Inc. Announces EMA Application Submission for Icotrokinra in Treating Moderate-to-Severe Plaque Psoriasis. Protagonist Therapeutics, Inc. announced that an application for icotrokinra has been submitted to the European Medicines Agency  by Johnson & Johnson. Icotrokinra is a pioneering investigational oral peptide aimed at treating moderate-to-severe plaque psoriasis in adults and adolescents aged 12 and older. This submission follows a similar application to the U.S. FDA and is supported by comprehensive Phase 3 study data, demonstrating significant efficacy and a favorable safety profile. The submission emphasizes icotrokinra's potential to revolutionize psoriasis treatment with the simplicity of a once-daily tablet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL39l01w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","JNJ","BK4534","IE00BDGV0183.EUR","LU2430703251.USD","IE00B3T34201.USD","LU1244550221.USD","LU1894683264.USD","LU1059921491.USD","LU0058720904.USD","LU1061106388.HKD","BK4588","LU1023059063.AUD","IE00B7SZLL34.SGD","LU1066051225.USD","IE00BVYPNW00.USD","LU1066053197.SGD","LU1066051811.HKD","SG9999002232.USD","BK4568","LU2430703178.SGD","BK4550","IE00BJT1NW94.SGD","PTGX","LU0070217475.USD","IE0034235303.USD","LU1074936037.SGD","LU1914381329.SGD","LU1506573853.SGD","IE00B2B36J28.USD","LU1674673428.USD","LU0345770993.USD","LU2592432038.USD","LU0795875169.SGD","LU2750360641.GBP","IE00B19Z3B42.SGD","LU1221951046.USD","BK4139","LU1674673691.USD","LU0114720955.EUR","BK4581","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0640476718.USD","LU2505996509.AUD","LU2471134952.CNY","IE00BN8TJ469.HKD","LU1929549753.HKD","BK4007","LU0912757837.SGD"],"gpt_icon":0},{"id":"2566998442","title":"Lakeland Industries price target lowered to $20 from $23 at DA Davidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2566998442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566998442?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:55","pubTimestamp":1757591715,"startTime":"0","endTime":"0","summary":"DA Davidson analyst Michael Shlisky lowered the firm’s price target on Lakeland Industries (LAKE) to $20 from $23 but keeps a Buy rating on the sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeland-industries-price-target-lowered-to-20-from-23-at-da-davidson-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeland-industries-price-target-lowered-to-20-from-23-at-da-davidson-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZL793.SGD","BK4568","IE00B19Z4B17.USD","IE0031619046.USD","LAKE","BK4202","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2566955217","title":"Poland - Factors to Watch September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2566955217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566955217?lang=en_us&edition=fundamental","pubTime":"2025-09-11 13:39","pubTimestamp":1757569166,"startTime":"0","endTime":"0","summary":"Poland - Factors to Watch September 11 WARSAW, Sept 11 (Reuters) - The following are significant news stories, press reports and events on Thursday. ALL TIMES GMT (Poland: GMT + 2 hours):DRONES OVER P","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL5N3UY055:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BK4568","BK4139","BK4566","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BK4585","LU0882574055.USD","LU1674673428.USD","LU1585245621.USD","LU2324357040.USD","SG9999015986.USD","LU0234570918.USD","BK4532","LU1430594728.SGD","LU0889565916.HKD","BK4583","LU0823416689.USD","LU1571399168.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1674673691.USD","SG9999015952.SGD","BK4550","LU1839511570.USD","LU1066051498.USD","SG9999015945.SGD","LU0114720955.EUR","LU2089984988.USD","LU2087621335.USD","GILD","LU0058720904.USD","IE0002270589.USD","LU0320765992.SGD","BK4578","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU2468319806.SGD","BK4588","IE00BKVL7J92.USD","LU1066053197.SGD","LU1778281490.HKD"],"gpt_icon":0},{"id":"2566398724","title":"Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2566398724","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566398724?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:54","pubTimestamp":1757537640,"startTime":"0","endTime":"0","summary":"- Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in the company’s previous Phase 2b challenge study - SOUTH SAN F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/10/3148254/25416/en/Vaxart-Reports-Additional-Phase-1-Data-Supporting-the-Potential-Efficacy-of-its-Second-Generation-Norovirus-Oral-Pill-Vaccine-Candidate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXRT","BK4139","BK4568"],"gpt_icon":0},{"id":"2566986103","title":"FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2566986103","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566986103?lang=en_us&edition=fundamental","pubTime":"2025-09-11 01:21","pubTimestamp":1757524860,"startTime":"0","endTime":"0","summary":"Top health officials under Kennedy are pushing for more transparency on Covid vaccine risks, focusing on pregnant women and child deaths, amid disputes with GOP lawmakers and industry leaders.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/10/Covid-19-Vaccine.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/10/Covid-19-Vaccine.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/fda/25/09/47604090/fda-moves-to-publicize-data-on-pregnant-womens-covid-vaccine-side-effects","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/09/47604090/fda-moves-to-publicize-data-on-pregnant-womens-covid-vaccine-side-effects","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4588","BK4551","BK4585","BK4535","BK4548","BNTX","BK4568","BK4139"],"gpt_icon":0},{"id":"2566988982","title":"BRIEF-Veeva Systems Says Gilead Sciences Commits To Veeva Vault CRM","url":"https://stock-news.laohu8.com/highlight/detail?id=2566988982","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566988982?lang=en_us&edition=fundamental","pubTime":"2025-09-10 23:25","pubTimestamp":1757517915,"startTime":"0","endTime":"0","summary":"BRIEF-Veeva Systems Says Gilead Sciences Commits To Veeva Vault CRMSept 10 (Reuters) - VEEVA SYSTEMS:GILEAD SCIENCES COMMITS TO VEEVA VAULT CRMSource text: ID:nPn7PBG1daFurther company coverage: VEEV.N ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA9FDLT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU1839511570.USD","IE00B3T34201.USD","LU0889565916.HKD","LU0234570918.USD","LU2324357040.USD","BK4528","BK4585","SG9999015945.SGD","LU2087621335.USD","LU1430594728.SGD","SG9999015952.SGD","GILD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0058720904.USD","SG9999015986.USD","BK4588","BK4139","IE00B19Z3581.USD","SG9999015978.USD","IE0002270589.USD","LU0266013472.USD","LU0320765992.SGD","LU1989764748.USD","BK4583","BK4568","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU0882574055.USD","BK4550","BK4613","IE00BSNM7G36.USD","BK4532","VEEV","LU1066053197.SGD","LU1674673691.USD","BK4578","BK4167","BK4534","LU0170899867.USD","LU1571399168.USD","LU0289739699.SGD","LU0823416689.USD","LU1989764664.SGD","LU1066051498.USD","IE00BKVL7J92.USD","BK4504","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2566600091","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2566600091","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566600091?lang=en_us&edition=fundamental","pubTime":"2025-09-10 23:07","pubTimestamp":1757516877,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts edged lower late Wednesday morning, declining 0.1% to 1,530.89 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which rose 6.1% and 6% respectively. They were followed by biotech firm Evaxion  and financial services company ING , which were up 5.6% and 2.9% respectively.The decliners from continental Europe were led by furniture maker Natuzzi  and biopharmaceutical company Genfit , which dropped 16% and 4.8% respectively. They were followed by software firm SAP  and biotech firm BioNTech , which fell 3.1% and 1.4% respectively.From the UK and Ireland, the gainers were led by biotech company Trinity Biotech  and insurance provider Prudential , which advanced 4.5% and 3.4% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Adaptimmune Therapeutics , which increas","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","SAP","BK4132","LU0162691827.USD","BK4023","BK4139","AKTX","BK4141","ADAP","BK4201","BK4532","PUK","BNTX","ING.AU","LU0320765646.SGD","NTZ","TRIB","BK4107","BK4095","LU1162221912.USD","CLLS","GNFT","BK4585","BK4162","BK4568","BK4551","BK4082","AFG","SQNS","ING","BK4613","BK4535","VOD","BK4117","BK4207","MREO","BK4505","LU0072461881.USD","EVAX","BK7505","BDRX","BK4528","BP","LU1829250122.USD","BK4548","BK4007","BK7141"],"gpt_icon":0},{"id":"2566600953","title":"Veeva Systems Expands Partnership With Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2566600953","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566600953?lang=en_us&edition=fundamental","pubTime":"2025-09-10 22:49","pubTimestamp":1757515799,"startTime":"0","endTime":"0","summary":"Veeva Systems  said Wednesday that Gilead Sciences  is expanding its partnership with the company by moving to Veeva's Vault CRM platform.Financial details were not provided.Vault CRM is part of suite of applications that offers the foundation for commercial execution, Veeva said.Price: 276.14, Change: -6.54, Percent Change: -2.31","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2458330243.SGD","LU1496350502.SGD","BK4566","IE00B19Z3B42.SGD","LU1674673428.USD","LU1791710582.SGD","LU0289961442.SGD","IE00BZ1G4Q59.USD","LU1803068979.SGD","LU2087621335.USD","IE00B19Z9505.USD","VEEV","LU0353189680.USD","LU0648001328.SGD","LU0289739699.SGD","IE00BQXX3D17.EUR","LU1046421795.USD","LU0081259029.USD","LU0234570918.USD","IE00B19Z8X17.USD","LU0689626769.HKD","GILD","BK4532","LU2286300806.USD","LU1951200564.SGD","LU0353189763.USD","LU0069063385.USD","LU1571399168.USD","LU2361045086.USD","LU1201861249.SGD","LU0943347566.SGD","LU2087625088.SGD","BK4613","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4538","LU1951198990.SGD","LU2756315318.SGD","BK4543","LU0310799852.SGD","BK4568","LU0048573561.USD","LU0238689110.USD","LU0980610538.SGD","LU0354030511.USD","LU2247934214.USD","LU0820562030.AUD","LU0889566641.SGD","LU0792757196.USD"],"gpt_icon":0},{"id":"2566022736","title":"Gilead Sciences Selects Veeva Vault CRM for Enhanced Commercial Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2566022736","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566022736?lang=en_us&edition=fundamental","pubTime":"2025-09-10 22:03","pubTimestamp":1757513001,"startTime":"0","endTime":"0","summary":"Veeva Systems Inc. has announced a new commitment from Gilead Sciences to adopt Veeva Vault CRM. This next-generation CRM system offers advanced capabilities, including agentic AI features designed to enhance commercial execution. Peter Gassner, CEO of Veeva, expressed honor in extending their strategic partnership with Gilead, a leader in innovative medicines for virology, inflammation, and oncology. Anna sberg, global CIO at Gilead Sciences, highlighted the shared commitment to advancing medicine and the potential of Veeva AI to elevate their commercial operations. The Vault CRM is part of Veeva's comprehensive suite of applications aimed at improving commercial efficiency and effectiveness through AI-driven tools.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL7TDvdW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU1839511570.USD","BK4566","LU0889565916.HKD","LU2324357040.USD","BK4528","BK4585","SG9999015945.SGD","LU2087621335.USD","LU1430594728.SGD","SG9999015952.SGD","GILD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0058720904.USD","SG9999015986.USD","BK4588","BK4139","IE00B19Z3581.USD","LU1674673428.USD","SG9999015978.USD","IE0002270589.USD","LU0266013472.USD","LU0320765992.SGD","LU1989764748.USD","BK4568","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU0882574055.USD","BK4550","BK4613","IE00BSNM7G36.USD","BK4532","VEEV","LU1674673691.USD","BK4578","BK4167","BK4534","LU0170899867.USD","LU1571399168.USD","LU0289739699.SGD","LU0109394709.USD","LU0823416689.USD","LU1989764664.SGD","LU1066051498.USD","IE00BKVL7J92.USD","LU1778281490.HKD","BK4504","IE00B19Z3B42.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":195,"code":"91000000","status":"200"}]}}